Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Formula: C8H12N4S3
Evofosfamide
respectively)
which blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma
KYA1797K was suggested to be used at 25 µM final concentration in vitro
AAE-581 - CAS# 354813-19-7 60167 Formula: C8H12N4S3Balicatib(AAE 581), CAS No. 354813 19 7, is a potent and selective inhibitor of cathepsin K; 10 100 fold more potent in cell based enzyme occupancy assays than against cathepsin B, L, and S. IC50 value: Target: cathepsin K The cathepsin K inhibitor AAE 581 (balicatib) as the most advanced of them passed Phase II clinical trials in 2005. Eighty adult female Macaca fascicularis underwent bilateral ovariectomies and were dosed twice daily by oral gavage
US$ 160.00
US$ 3999.50
US$ 1349.50
US$ 2999.50
US$ 849.50
US$ 32.20
US$ 1749.50
US$ 799.50